Bristol Myers Squibb (CELG-RI) Interest & Investment Income (2009 - 2013)

Bristol Myers Squibb has disclosed Interest & Investment Income across 3 years of filings, most recently posting $25.0 million for Q1 2013.

• In Q1 2013, Interest & Investment Income fell 30.56% year-over-year to $25.0 million; the TTM figure through Dec 2009 stood at $220.0 million (changed N/A YoY), while the FY2012 annual figure was $106.0 million, up 16.48% from the prior year.
• Interest & Investment Income retreated to $25.0 million in Q1 2013, from $36.0 million in the prior quarter.
• Over the last five years, Interest & Investment Income for CELG-RI reached as high as $220.0 million in Q4 2009 and fell as low as $25.0 million in Q1 2013.
• The 3-year median for Interest & Investment Income is $36.0 million (2012), against an average of $93.7 million.
• The widest YoY moves for Interest & Investment Income: up 30.56% in 2013, down 30.56% in 2013.
• A 3-year view of Interest & Investment Income shows it stood at $220.0 million in 2009, then sank by 83.64% to $36.0 million in 2012, then tumbled by 30.56% to $25.0 million in 2013.
• According to Business Quant data, Interest & Investment Income over the past three periods registered $25.0 million, $36.0 million, and $220.0 million for Q1 2013, Q1 2012, and Q4 2009 respectively.